Andrea Loewen, SVP, Global Regulatory Affairs at REATA PHARMACEUTICALS INC (RETA), sold 36,872 shares at $83.36 ($3.1M) on 2023-03-07, disclosed to the SEC on 2023-03-09.
Open-market sale of $3.1M RETA by SVP, Global Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.36 | 17,836 | $1.5M | 48.4% |
| 2 | $83.36 | 17,836 | $1.5M | 48.4% |
| 3 | $84.44 | 1,200 | $101K | 3.3% |
| Total | $83.40 avg | 36,872 | $3.1M | 100% |
| Filing → |
| RETA | SELL | 2023-03-06 | $301K | — | Filing → |